Search - tctmd.com

Displaying 1 - 20 of 61

Sort: Relevancy | Date

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

L.A. McKeown

May 06, 2024

News Conference News ISET 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

Caitlin E. Cox

January 30, 2024

News Daily News

High-Sensitivity Troponins May Overestimate PE Severity

L.A. McKeown

November 28, 2023

News Conference News VIVA 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

L.A. McKeown

November 01, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Daily News

VTE Risk Higher With COVID-19 Than With Flu

Todd Neale

August 18, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

Michael O'Riordan

February 23, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Daily News

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

Todd Neale

November 25, 2021

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

L.A. McKeown

November 18, 2021

News Opinion CV Team Dispatch

October 2021 News Roundup

L.A. McKeown

October 01, 2021

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

Shelley Wood

September 13, 2021

Advertisement

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

November 2024 Dispatch for the CV Team

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

High-Sensitivity Troponins May Overestimate PE Severity

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

October 2023 News Roundup

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

VTE Risk Higher With COVID-19 Than With Flu

PAD Significantly Ups Morbidity and Mortality in AMICS

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

FDA Approves Two Additional Indications for Rivaroxaban in Children

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

October 2021 News Roundup

Long-term Anticoagulation After Unprovoked VTE: New Insights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content